News & Announcements

Join NJ ACTS for a Special Lecture on 12/19, 12-1:30

Resources for Researchers through the CTSA Trial Innovation Network Daniel Ford, MD, MPH Director, Johns Hopkins Institute for Clinical and Translational Research and Dixie Thompson, BSN, RN Director of Research & Science Utah Clinical & Translational Science...

NJIT Researcher Uses Nanoparticles to Develop Cancer Therapies.

NJIT Researcher Uses Nanoparticles to Develop Cancer Therapies.

NJIT’s Kathleen McEnnis, assistant professor of chemical and materials engineering, is pioneering a new approach in cancer treatment through innovative drug-delivery nanoparticles. Her research focuses on treating aggressive types of breast cancer, using...

New NJACTS Publication

Please read Dr. Balevic's article in JAMA Network Open titled, "Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial." Infection with COVID-19 can result in a clinical...